TrialOncogene2014
Low CHD5 expression activates the DNA damage response and predicts poor outcome in patients undergoing adjuvant therapy for resected pancreatic cancer.
W A Hall et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
21 papers cite it
this papercites it